bronchodilator agents

Preferred Label : bronchodilator agents;

MeSH definition : Agents that cause an increase in the expansion of a bronchus or bronchial tubes.;

MeSH synonym : agents, bronchial-dilating; agents, bronchodilator; bronchial-dilating agents; bronchial dilating agents; bronchodilators; Bronchodilator; Bronchodilator Agent; Agent, Bronchodilator;

MeSH hyponym : broncholytic agents; Agents, Broncholytic; Broncholytic Agent; Agent, Broncholytic;

Related MeSH term : broncholytic effect; bronchodilator effect; Effect, Broncholytic; Broncholytic Effects; Effects, Broncholytic; Effect, Bronchodilator; Bronchodilator Effects; Effects, Bronchodilator;

MeSH annotation : note entry term BRONCHODILATOR EFFECT: use only for the bronchodilator effect of a chemical substance;

Wikipedia link : https://en.wikipedia.org/wiki/Bronchodilator agents;

Is substance : O;

action pharmacologique : O;

Details

Origin ID

D001993;

UMLS CUI

C0006280;

ATC code(s)
- bambuterol [ATC Code]
- clenbuterol [ATC Code]
- fenoterol [ATC Code]
- isoprenaline [ATC Code]
- reproterol [ATC Code]
- terbutaline [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- BOWEN'S DISEASE [WHO-ART Included Term]
- Babaodan Capsule [NCIt concept]
- Bangladesh [NCIt concept]
- Behcet syndrome [OMIM Phenotype]
- Birth Date [NCIt concept]
- Block Design Subtest (WPPSI-IV) [NCIt concept]
- Bowen's disease [MedDRA Preferred Term]
- Bronchodilation [NCIt concept]
- Comics [UNESCO concept]
- Maltose tetrapalmitate (substance) [SNOMED CT concept]
- Twice Daily [NCIt concept]
- bowen's disease [SNOMED Notion]
- comics [CISMeF resources Type]
- during bronchodilation [LOINC Challenge]
CISMeF manual mappings
- Poisoning caused by bronchodilator drug (disorder) [SNOMED CT concept]
Currated CISMeF NLP mapping
- Bronchodilator [NCIt concept]
- Bronchodilator [ICD-11 Extension code]
- Bronchodilator [ICHI extension code]
- Bronchodilator (substance) [SNOMED CT concept]
- Bronchodilators [LOINC component]
- bronchodilation [Disease (Nov.)]
Indexing information
- 2,4-diamino-5-cyano-6-bromopyridine [MeSH Supplementary Concept]
- PL-3994 [MeSH Supplementary Concept]
- mequitazine [MeSH Supplementary Concept]
- revefenacin [MeSH Supplementary Concept]
Record concept(s)
- bronchodilator agents [MeSH concept]
- bronchodilator effect [MeSH concept]
- broncholytic agents [MeSH concept]
- broncholytic effect [MeSH concept]
See also
- bronchi [MeSH Descriptor]
- histamine h1 antagonists [MeSH Descriptor]
See also inter- (CISMeF)
- Bronchodilation [LOINC Challenge]
- Long-Acting beta2-adrenergic receptor Agonist [SYNODOS term]
- Medicinal product acting as bronchodilator (product) [SNOMED CT concept]
- long-acting anticholinergic [SYNODOS term]
Semantic type(s)
- Pharmacologic Substance [UMLS semantic type]
Substance(s)
- 1-(5-hydroxy-5-methylhexyl)-3-methylxanthine [MeSH Supplementary Concept]
- Cilostazol [MeSH Descriptor]
- Fluticasone [MeSH Descriptor]
- Fluticasone-Salmeterol Drug Combination [MeSH Descriptor]
- Formoterol Fumarate [MeSH Descriptor]
- MEN 11420 [MeSH Supplementary Concept]
- Mometasone Furoate, Formoterol Fumarate Drug Combination [MeSH Descriptor]
- S-nitrosoglutathione [MeSH Descriptor]
- S-nitrosothiols [MeSH Descriptor]
- Salmeterol Xinafoate [MeSH Descriptor]
- Tiotropium Bromide [MeSH Descriptor]
- acefyllin piperazinate [MeSH Supplementary Concept]
- adrenomedullin [MeSH Descriptor]
- albuterol [MeSH Descriptor]
- allapinin [MeSH Supplementary Concept]
- ambuphylline [MeSH Supplementary Concept]
- aminophylline [MeSH Descriptor]
- atropine [MeSH Descriptor]
- azelastine [MeSH Supplementary Concept]
- bambuterol [MeSH Supplementary Concept]
- bamifylline [MeSH Supplementary Concept]
- betamethasone acetate phosphate [MeSH Supplementary Concept]
- bimakalim [MeSH Supplementary Concept]
- bitolterol [MeSH Supplementary Concept]
- budesonide [MeSH Descriptor]
- carbinoxamine, dextromethorphan, pseudoephedrine drug combination [MeSH Supplementary Concept]
- cholinophyllin [MeSH Supplementary Concept]
- clenbuterol [MeSH Descriptor]
- clorprenaline [MeSH Supplementary Concept]
- colforsin [MeSH Descriptor]
- cromakalim [MeSH Descriptor]
- dimephosphon [MeSH Supplementary Concept]
- diniprofylline [MeSH Supplementary Concept]
- diphemanil methylsulfate [MeSH Supplementary Concept]
- doxantrazole [MeSH Supplementary Concept]
- doxofylline [MeSH Supplementary Concept]
- dyphylline [MeSH Descriptor]
- enprofylline [MeSH Supplementary Concept]
- epinephrine [MeSH Descriptor]
- etamiphylline [MeSH Supplementary Concept]
- etofylline [MeSH Supplementary Concept]
- fenoterol [MeSH Descriptor]
- fenoterol, ipratropium drug combination [MeSH Supplementary Concept]
- fenspiride [MeSH Supplementary Concept]
- hexoprenaline [MeSH Descriptor]
- hyoscyamine [MeSH Descriptor]
- ibudilast [MeSH Supplementary Concept]
- ipratropium [MeSH Descriptor]
- isoetharine [MeSH Descriptor]
- isoproterenol [MeSH Descriptor]
- isospaglumic acid [MeSH Supplementary Concept]
- khellin [MeSH Descriptor]
- mabuterol [MeSH Supplementary Concept]
- metaproterenol [MeSH Descriptor]
- nitric oxide [MeSH Descriptor]
- olodaterol [MeSH Supplementary Concept]
- pirbuterol [MeSH Supplementary Concept]
- procaterol [MeSH Descriptor]
- proxyphylline [MeSH Supplementary Concept]
- pseudoephedrine [MeSH Descriptor]
- racepinephrine [MeSH Descriptor]
- reproterol [MeSH Supplementary Concept]
- rilmakalim [MeSH Supplementary Concept]
- terbutaline [MeSH Descriptor]
- theobromine [MeSH Descriptor]
- theophylline [MeSH Descriptor]
- tiaramide [MeSH Supplementary Concept]
- tretoquinol [MeSH Descriptor]
- tulobuterol [MeSH Supplementary Concept]
- ularitide [MeSH Supplementary Concept]
- verlukast [MeSH Supplementary Concept]
- zardaverine [MeSH Supplementary Concept]
UMLS correspondences (same concept)
- Bronchodilator [ICD-11 Extension code]
- Bronchodilator [NCIt concept]
- Bronchodilator (substance) [SNOMED CT concept]
- Bronchodilators [LOINC component]
- Medicinal product acting as bronchodilator (product) [SNOMED CT concept]
- bronchodilation [Disease (Nov.)]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients